Stay updated with breaking news from Futuresearch Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), which specialises in medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies, has...
Public Announcement Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea ...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has appointed two highly experienced lead principal investigators...
Incannex Healthcare recruited two lead principal investigators for a phase 2/3 clinical trial investigating IHL-42X for the treatment of OSA.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has appointed two highly experienced lead principal investigators (PIs) for its Phase 2/3 clinical trial of...